Posts by: Ana Pena

Ana Pena

September 14, 2018September 19, 2018

Phagocytes, Key Immune Cells, Seen to Switch from Promoting to Repairing MS Lesions in Study

News

Phagocytes, diverse cells of the innate immune system, are known to both promote and prevent inflammation, depending on whether they are programed to damage tissue or to ... Read more

September 12, 2018September 14, 2018

Fat Carrier Protein May Protect Nerve Cells, Help Myelin Regrow During MS, Research Suggests

News

Apolipoprotein D (Apo D), a brain-produced carrier of fat molecules, seems to have a neuroprotective role and helps in the regrowth of myelin during multiple sclerosis ... Read more

September 11, 2018September 13, 2018

Truly ‘Benign MS’ Evident in Only Small Minority of Patients, Large UK Study Reports

News

Multiple sclerosis (MS) that appears to be “genuinely benign” 15 years after diagnosis is evident in a small number of patients, a large population-based study from the ... Read more

September 10, 2018September 10, 2018

‘Guardian’ Immune Cells of Brain Respond Differently by Sex, Study of Male and Female Mice Reports

News

Gender differences are evident in immune system cells of the brain called microglia, a study in male and female mice reports, suggesting these cells’ sex-specific features ... Read more

September 7, 2018September 11, 2018

How B-cells Work to Promote T-cell Attacks on Myelin That Lead to MS Detailed in Study

News

B-cells in the immune system play an important role in the unfolding of inflammation and brain lesions in multiple sclerosis (MS), largely by how they influence ... Read more

August 20, 2018August 20, 2018

Hypertension and Heart Disease Linked to Increase in Brain Atrophy in Long-term Study

News

High blood pressure and heart disease are linked to greater loss of brain mass, or atrophy in white matter and whole brain volume, in people with ... Read more

August 14, 2018August 14, 2018

Detailed Map of Mouse Nervous System May Help Uncover Origin of Neurological Diseases, Including MS

News

Researchers have created a detailed map of the mouse nervous system, including the location of the many diverse cell types in the brain, in the largest ... Read more

August 6, 2018August 6, 2018

Glatect, Alternative to Copaxone, Added to Public Health Plans of 5 Canadian Provinces

News

Pendopharm’s Glatect (glatiramer acetate injection), a lower cost alternative to Teva’s Copaxone, has been added to the public health plans of five Canadian provinces for patients with ... Read more

August 2, 2018August 6, 2018

Multiple Sclerosis Patients Identify Symptoms that Worsen Quality of Life

News

Loss of health-related quality of life is caused mostly by balance problems, muscle stiffness, and depression in people with relapsing-remitting multiple sclerosis (RRMS), and for those with ... Read more

July 24, 2018July 24, 2018

Cerebrospinal Fluid Neurofilament Predicts CIS and RRMS Progression, Study Contends

News

Cerebrospinal fluid levels of neurofilament light chain, a protein associated with nerve cell damage, can predict disease progression in people with clinical isolated syndrome (CIS) and ... Read more

July 23, 2018July 27, 2018

Shorter Washout Period Lessens Relapse Risk When Switching from Tysabri to Gilenya in RRMS, Study Finds

News

Shortening the washout period to four weeks when switching from Biogen’s Tysabri to Novartis’ Gilenya is safe and reduces the chances of experiencing a disease flare ... Read more

July 12, 2018July 18, 2018

Missouri Trial to Examine if Fasting Alters Gut Microbiome and Immune System of RRMS Patients in Helpful Ways

News

A 12-week clinical study is recruiting people with relapsing-remitting multiple sclerosis (RRMS) to evaluate if intermittent fasting can improve their immune response, metabolism, and gut microbiome ... Read more

July 6, 2018July 12, 2018

Mix of Organic Solvent Exposure, Smoking and Genes Raise Risk of MS by 30 Fold, Study Says

News

Exposure to organic solvents like such as paint or varnish greatly raises the risk of multiple sclerosis (MS), particularly in people who smoke or have a genetic ... Read more

June 22, 2018June 25, 2018

Researchers Discover How Key Genetic Risk Factor for MS Operates

News

Scientists have uncovered the molecular mechanism by which the genetic variant HLA-DRB1*15:01 is the strongest risk factor for multiple sclerosis, new research shows. Analyzing several studies, ... Read more

May 23, 2018May 23, 2018

Subcutaneous Ofatumumab a Safe, Effective RRMS Therapy at Low Doses, Trial Results Show

News

A formulation of ofatumumab (brand name Arzerra) to be injected under the skin (subcutaneous) was found to be safe and effective in the treatment of relapsing-remitting ... Read more

April 6, 2018April 6, 2018

Online Meditation Course Seen to Help MS Patients Manage Symptoms in Clinical Trial

News

Online training in  meditation based on mindfulness can improve the quality of life for multiple sclerosis (MS) patients while easing depression, anxiety, and sleep problems, a study conducted ... Read more

March 29, 2018May 21, 2018

Ocrevus Outperforms Rebif in Preventing Relapsing MS Activity, Analysis Shows

News, Ocrevus

Ocrevus (ocrelizumab) was more effective than Rebif (interferon beta-1a) at preventing relapsing multiple sclerosis activity, according to an analysis that covered two Phase 3 clinical trials. The comparison ... Read more

March 1, 2018March 1, 2018

Young Researchers in Multiple Sclerosis Earn Awards at ACTRIMS Forum 2018

News

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) has awarded five young investigators for their research work on multiple sclerosis (MS). The awards were ... Read more

February 23, 2018February 27, 2018

Pilot Study Is Testing Whether Mediterranean Diet Can Help MS Patients

News

New York researchers are doing a pilot study of whether a Mediterranean diet can reduce multiple sclerosis symptoms and improve patients’ quality of life.  Dr. Ilana B. ... Read more

February 22, 2018February 22, 2018

MS Patients Tend to Have More Heart Problems, Need Better Exams, Study Shows

News

Researchers found that patients with multiple sclerosis (MS) have increased heart problems suggestive of an intrinsic myocardial disease, and would benefit from cardiovascular examinations using more ... Read more

February 12, 2018February 12, 2018

Stigma Can Be a Cause of MS Patients’ Depression, Study Shows

News

The stigma of multiple sclerosis can increase patients’ risk of depression, but a socially supportive environment, a sense of belonging and a sense of independence can ... Read more

January 29, 2018January 29, 2018

Variations in Biological Clock Genes May Increase Risk of MS, Study Reports

News

Researchers have found a link between variations in two genes that control our 24-hour biological clock and the risk of a person developing multiple sclerosis. The ... Read more

January 25, 2018January 26, 2018

Holland Approves Clinical Trial Plans for AXIM’s Cannabis-based Gum for MS Pain and Spasticity

News

Dutch regulators have signed off on AXIM Biotechnologies’ clinical trial plans for a chewing gum that offers controlled release of cannabinoids to treat multiple sclerosis patients’ pain and spasticity. ... Read more

January 17, 2018January 17, 2018

Majority of RRMS Patients in Swedish Study Seen to Stop Using Tecfidera Within 2 Years

News

A majority of relapsing-remitting multiple sclerosis (RRMS) patients at a Swedish clinic who initiated treatment with Tecfidera (dimethyl fumarate; DMF) either stopped or switched to another ... Read more